US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 18.800
  • +0.750+4.16%
Close Nov 22 16:00 ET
  • 18.800
  • 0.0000.00%
Post 20:01 ET
703.50MMarket Cap13.06P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.938M--
--2024/Q4-- / 13.154M--
--2024/Q319.570M / 11.875M--
--2024/Q294.694M / 36.433M--
--2024/Q159.120M / 15.195M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.938M--
--2024/Q4-- / 13.154M--
--2024/Q319.570M / 11.875M--
--2024/Q294.694M / 36.433M--
--2024/Q159.120M / 15.195M--

Unlock Free Earnings Estimates

Entrada Therapeutics Earnings Reports

  • Entrada Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 07:16 ET

  • Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 5 07:11 ET

  • Entrada Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 07:17 ET

  • Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 13 07:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data